---
title: CHF
layout: diseases
author: Corbin Cox
last-updated: 2018-12-17
created: 2018-12-17
toc: true
common: false
---

# Dx[^yancy2013]

* HFrEF: HF w/ LVEF &le; 40%
* HFpEF: HF w/ LVEF &ge; 50%
  * &gt; 40% is borderline HFpEF
* Measure NT-proBNP or BNP if suspicious
* CXR and Doppler Echo on initial workup

## Staging / Classification

AHA Stages
{: .caption}

| Stage | Description                                           |
| ----- | ----------------------------------------------------- |
| A     | High risk w/o structural heart disease and w/o HF SSx |
| B     | SHD w/o SSx of HF                                     |
| C     | SHD w/ current or prior HF SSx                        |
| D     | Refractory HF SSx                                     |

NYHA Classifications
{: .caption}

| Classification | Description                                 |
| -------------- | ------------------------------------------- |
| I              | No limitations of physical activity d/t SSx |
| II             | Normal physical activity results in SSx     |
| III            | Mild physical activity results in SSx       |
| IV             | SSx at rest                                 |

## DDx of Dilated Cardiomyopathies

* Genetic / Familial
* Obesity
* DM
* Hyperthyroidism
* Acromegaly
* EtOH
* Cocaine
* HER-2 and/or anthracyclines
* Various other toxins
* Chronic Tachycardia
* Myocarditis
  * SLE
  * HIV
  * Other infections
  * Chagas disease
  * Hypersensitivity myocarditis
  * Scleroderma and other rheumatologist conditions
* Peripartum cardiomyopathy
* Hemochromatosis and iron overload
* Amyloidosis

# Tx (HFrEF)[^yancy2013]<sup>,</sup> [^yancy2017]

## Stage A

* Modify risk factors as appropriate, with emphasis on wt loss, smoking cessation, BP control, HLD control, and DM control

## Stage B

All pts should receive...

* ACEI (ARB if CI)
* &beta;-blocker
  * Metoprolol tartrate
  * Bisoprolol
  * Carvedilol
* Statins (if Hx of ACS or CAD)
* Other means of BP control PRN
  * Consider spironolactone if HTN is refractory to above agents
* Consider prophylactic ICD

## Stage C

All pts should receive...

* ACEI or ARB or ARNI
  * Tolerating ACEI or ARB and able to afford => transition to ARNI
  * **Do not give ARNI w/i 36hr of ACEI or ARB**
  * **Do not give ARNIs to pts w/ Hx of angioedema**
  * Monitor and titrate slowly Q1-2wks
* &beta;-blocker
  * Metoprolol tartrate
  * Bisoprolol
  * Carvedilol
  * Consider ivabridine if on maximum BB dose, LVEF &le; 35%, and RHR &ge; 70
  * Start low and titrate up when SSx of current dose abide
* Spironolactone
  * CrCl &gt; 30 and K &lt; 5
  * If LVEF &le; 35% OR LVEF &le; 40% w/ HF or DM after MI
* Consider Hydralazine-Nitrate combos in black pts
* PRN Diurectics for fluid status control
  * Preferably Loops, with thiazides added for diuretic resistance PRN
* Additional BP Meds PRN for goal of &lt; 130/80
* Consider Digoxin to decrease hospitalizations
  * 0.125-0.25mg QD NTE 0.5-0.75mg QD
  * Goal Plasma Range of 0.5-0.9 ng/mL
* **Avoid CCBs except amlodipine**

## Dosing

HF Drug Dosing
{: .caption}

<table>
  <thead>
    <tr>
      <th>Drug</th>
      <th>Initial Dose</th>
      <th>Max Dose</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td colspan="3">ACEIs</td>
    </tr>
    <tr>
      <td>Captopril</td>
      <td>6.25mg TID</td>
      <td>50mg TID</td>
    </tr>
    <tr>
      <td>Enalapril</td>
      <td>2.5mg BID</td>
      <td>10-20mg BID</td>
    </tr>
    <tr>
      <td>Lisinopril</td>
      <td>2.5-5mg QD</td>
      <td>20-40mg QD</td>
    </tr>
    <tr>
      <td colspan="3">ARBs</td>
    </tr>
    <tr>
      <td>Candesartan</td>
      <td>4-8mg QD</td>
      <td>32mg QD</td>
    </tr>
    <tr>
      <td>Losartan</td>
      <td>25-50mg QD</td>
      <td>50-150mg QD</td>
    </tr>
    <tr>
      <td>Valsartan</td>
      <td>20-40mg BID</td>
      <td>160mg BID</td>
    </tr>
    <tr>
      <td colspan="3">ARNI</td>
    </tr>
    <tr>
      <td>Sacubitril/Valsartan</td>
      <td>49mg/51mg BID<br>(or 24mg/26mg BID)</td>
      <td>97mg/103mg BID</td>
    </tr>
    <tr>
      <td colspan="3">I<sub>f</sub> Channel Inhibitor</td>
    </tr>
    <tr>
      <td>Ivabradine</td>
      <td>5mg BID</td>
      <td>7.5mg BID</td>
    </tr>
    <tr>
      <td colspan="3">Aldosterone Antagonists</td>
    </tr>
    <tr>
      <td>Spironolactone</td>
      <td>12.5-25mg QD</td>
      <td>25mg QD or BID</td>
    </tr>
    <tr>
      <td>Eplerenone</td>
      <td>25mg QD</td>
      <td>50mg QD</td>
    </tr>
    <tr>
      <td colspan="3">Î²-Blockers</td>
    </tr>
    <tr>
      <td>Bisoprolol</td>
      <td>1.25mg QD</td>
      <td>10mg QD</td>
    </tr>
    <tr>
      <td>Carvedilol</td>
      <td>3.125mg BID</td>
      <td>50mg BID</td>
    </tr>
    <tr>
      <td>Carvedilol CR</td>
      <td>10mg QD</td>
      <td>80mg QD</td>
    </tr>
    <tr>
      <td>Metoprolol Succinate</td>
      <td>12.5-25mg QD</td>
      <td>200mg QD</td>
    </tr>
    <tr>
      <td colspan="3">ISDN-Hydralazine</td>
    </tr>
    <tr>
      <td>Combo Pill</td>
      <td>20mg/37.5mg TID</td>
      <td>40mg/75mg TID</td>
    </tr>
    <tr>
      <td>Individual Pills</td>
      <td>20-30mg/25-50mg TID or QD</td>
      <td>40mg TID / 100mg TID</td>
    </tr>
  </tbody>
</table>
HF Diuretic Dosing
{: .caption}

<table>
  <thead>
    <tr>
      <th>Drug</th>
      <th>Initial Dose</th>
      <th>Max TDD</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td colspan="3">Loops</td>
    </tr>
    <tr>
      <td>Bumetanide</td>
      <td>0.5-1mg QD-BID</td>
      <td>10mg</td>
    </tr>
    <tr>
      <td>Furosemide</td>
      <td>20-40mg QD-BID</td>
      <td>600mg</td>
    </tr>
    <tr>
      <td>Torsemide</td>
      <td>10-20mg QD</td>
      <td>200mg</td>
    </tr>
    <tr>
      <td colspan="3">Thiazides</td>
    </tr>
    <tr>
      <td>Chlorthiazide</td>
      <td>250-500mg QD-BID</td>
      <td>1000mg</td>
    </tr>
    <tr>
      <td>Chlorthalidone</td>
      <td>12.5-25mg QD</td>
      <td>100mg</td>
    </tr>
    <tr>
      <td>HCTZ</td>
      <td>25mg QD or BID</td>
      <td>200mg</td>
    </tr>
    <tr>
      <td>Indapamide</td>
      <td>2.5mg QD</td>
      <td>5mg</td>
    </tr>
    <tr>
      <td>Metolazone</td>
      <td>2.5mg QD</td>
      <td>20mg</td>
    </tr>
    <tr>
      <td colspan="3">K-Sparing</td>
    </tr>
    <tr>
      <td>Amiloride</td>
      <td>5mg QD</td>
      <td>20mg</td>
    </tr>
    <tr>
      <td>Spironolactone</td>
      <td>12.5-25 QD</td>
      <td>50mg</td>
    </tr>
    <tr>
      <td>Triamterene</td>
      <td>50-75mg BID</td>
      <td>200mg</td>
    </tr>
  </tbody>
</table>
## Stage D

* Fluid restrict to 1.5-2 L QD
* Consider milrinone or dobutamine for inotropy
* Consider LVAD
* Consider transplant

# Acute Decompensated HF[^yancy2013]<sup>,</sup> [^tintinalli]

* Continue home HF meds unless CI or hemodynamically unstable / failing renal Fx
* IV diuretics for fluid-overloaded pts
  * Furosemide 40mg, Bumetanide 1-3mg, or Torsemide 10-20mg for naive pts
  * Should give higher doses than home
* Give vasodilators if pt has adequate hemodynamics and significant dyspnea
  * NTG 0.5-0.7 mcg/kg/min IV titrated NTE 200 mcg/min
  * Nitroprusside 0.3 mcg/kg/min titrated q5-10min
  * Nesiritide 2mcg/kg then 0.01 mcg/kg/min[^lexi]
* Pressors / Inotropes if not perfusing
  * Milrinone 50 mcg/kg over 10min then 0.5 mcg/kg/min
  * Dobutamine 2-20 mcg/kg/min
* Consider LVAD or ECMO if absolutely necessary



# References
{% include sources.md %}